Ciwon zuciya wanda yake asymptomatic na dogon lokaci. Hadarin mutuwa yana da yawa sosai

Haɗarin mutuwa a cikin marasa lafiya na ciwon zuciya tare da gazawar zuciya ya ninka sau biyu bayan tsayawa a asibiti fiye da da. Kowane majiyyaci da aka gano tare da ciwon zuciya yana da haɗari mai haɗari, in ji Farfesa Małgorzata Lelonek, FESC, FHFA, shugaban Sashen Harkokin Kiwon Lafiyar Zuciya a Jami'ar Likita ta Lodz. Kuma akwai kusan miliyan 1,3 na waɗannan marasa lafiya a Poland.

1. Ana kiran gazawar zuciya "cututtukan shiru" saboda cutar ba ta haifar da alamu na yau da kullun ba.
2. Kasar Poland ita ce ta farko a cikin kasashe 37 da suka ci gaba sosai wajen yawan majinyatan da ke kwance a asibiti sakamakon wannan cuta
3. Dole ne magani don gazawar zuciya ya kasance mai ƙarfi, sauri da aminci. Lokaci yana da mahimmanci: dole ne mu yi aiki ta yadda za mu ceci rayuwar majiyyaci akan lokaci - ya jaddada prof. Lelonek
4. Ana iya samun ƙarin bayani akan shafin farko na Onet

Kamar yadda prof. Małgorzata Lelonek, FESC, FHFA, shugaban Sashen Kula da Cututtukan Cardiology a Jami'ar Kiwon Lafiya ta Lodz, wani nau'i mai mahimmanci a cikin rashin lafiyar zuciya shine babban haɗarin asibiti saboda haɓakar cututtukan da ke ciki da kuma rashin jin daɗi bayan kowane asibiti. , sakamakon ci gaban ciwon zuciya.

Ciwon zuciya cuta ce mai hatsarin gaske

- Asibiti a cikin gazawar zuciya yana tabbatar da ci gaban cututtuka: cutar tana ci gaba kuma magani na yanzu ya zama bai isa ba. Abin takaici, wannan yana fassara zuwa damar marasa lafiya. Haɗarin mace-mace a cikin gazawar zuciya ya ninka sau biyu bayan asibiti don rashin lafiyar zuciya fiye da kafin a kwantar da shi a asibiti. Mun sani daga binciken PARADIGM-HF cewa marasa lafiya da ke da tarihin asibiti don rashin ciwon zuciya suna da kusan kusan sau bakwai mafi girma na mutuwa daga cututtukan zuciya fiye da marasa lafiya waɗanda ba a kwantar da su a asibiti don ciwon zuciya ba, in ji Farfesa Małgorzata Leonek.

- Mun san daga wannan binciken cewa ko da majiyyatan mu suna da alamun barga; ba su sami karuwar cutar ba, har yanzu kamar kashi 20 cikin dari. daga cikin su suna fuskantar mutuwar zuciya da jijiyoyin jini ko kuma kwantar da su a asibiti saboda tsananin gazawar zuciya. Daga cikin wannan yawan jama'a, fiye da rabin marasa lafiya suna mutuwa da mutuwar zuciya ta gaggawa (NSA). Wadannan bayanan suna nufin cewa majinyacin da aka gano da ciwon zuciya ta atomatik ya zama majiyyaci mai haɗari ba tare da la'akari da wasu dalilai ba, duka dangane da mutuwar zuciya da kuma yawan mace-mace. Kuma wannan babban haɗarin kuma yana ƙaruwa lokacin da asibitocin ke faruwa a yayin raunin zuciya. Wannan yana nufin cewa majiyyaci tare da gazawar zuciya dole ne a bi da shi lokaci guda: da sauri, da ƙarfi da kuma nan da nan ta hanya mafi inganci. In ba haka ba, ƙila ba za mu iya ceton ransa ba - in ji shi.

Ciwon zuciya. Menene alamomin?

A cewar shugabar kungiyar ta kasawar zuciya ta PTK, daya daga cikin muhimman fa'idodin zamani na maganin cututtukan zuciya shine saurin da suke yi. Mai haƙuri yana samun ci gaba a cikin kwanaki, ba makonni ba. Sabbin nau'ikan jiyya sune, a cewar prof. Małgorzata Lelonek kuma yana da lafiya - a cikin yanayin phyllos, ba sa buƙatar sarrafa sigogi na dakin gwaje-gwaje, wanda shine babban kalubale ga mai haƙuri.

- Bayan 'yan kwanaki kawai na amfani da nau'ikan magunguna na zamani, marasa lafiyarmu sun yarda cewa suna numfashi da sauƙi, sun fi aiki da inganci. Marasa lafiya ba sa gajiya da sauƙi kamar kafin aiwatar da maganin. Duk wannan yana da matukar tasiri mai tasiri akan ingancin rayuwar marasa lafiya, tunanin su na 'yancin kai, hukuma, da gamsuwa da rayuwa. A fagen ilimin harhada magunguna, misali mai ban sha'awa na ingantaccen bayani shine dapagliflozin. Wannan kwayar halitta tana da ƙaƙƙarfan shaidar asibiti don tallafawa rage yawan mace-mace a cikin marasa lafiya da raunin zuciya. A cikin marasa lafiya da ke karɓar wannan farfadowa, binciken DAPA-HF ya nuna raguwar 17% a cikin haɗarin mutuwa. da raguwar mace-mace daga cututtukan zuciya da 18%. – in ji prof. Małgorzata Lelonek.

- A cikin binciken DAPA-CKD da aka gudanar a cikin rukunin marasa lafiya da ke fama da ciwon koda (daga cikin marasa lafiya waɗanda, saboda cutar da ke tare da ciwon zuciya, suna da nauyi da yawa kuma don haka mummunan hasashe), an tabbatar da raguwar mace-mace. ku 31%! Mahimmanci, an nuna tasiri mai amfani wajen rage yawan mace-mace ko da kuwa ko marasa lafiya suna da ciwon zuciya ko a'a. Wannan yana nufin cewa maganin da aka yi nazari ya kasance mai tasiri har ma a cikin marasa lafiya da yawa - in ji masanin.

Ciwon zuciya. Menene maganin yayi kama?

- A cikin binciken PARADIGM-HF, ba a gwada sacubitril / valsartan ba idan aka kwatanta da placebo amma ga sauran kwayoyin gwajin da aka ambata, har zuwa enalapril, mai kwatanta aiki. A wannan yanayin, miyagun ƙwayoyi na binciken ya nuna raguwar mace-mace, wanda ya tabbatar da cewa tasirinsa na warkewa ya fi na mai hana ACE. A cikin binciken DAPA-HF, kusan kashi 8. Marasa lafiya a cikin yawan binciken suna shan sacubitril / valsartan, amma ba tare da la'akari da ko mai haƙuri yana shan maganin ko a'a ba, tasirin jiyya tare da dapagliflozin ya yi daidai. Wannan yana nufin cewa dapagliflozin ya nuna ƙarin fa'ida ba tare da fa'idar fa'idar sacubitril / valsartan ba. Wannan yana nufin cewa miyagun ƙwayoyi yana da yuwuwar ƙara haɓaka inganci da tsawon rai na mai haƙuri. Waɗannan sababbin hanyoyin da za a iya amfani da su ne na jiyya - ya bayyana prof. Małgorzata Lelonek.

A cewar shugabar shugabar tazarshen gazawar zuciya ta Poland City-Poland, ana amfani da PRAPHATHERACK a cikin jiyyar gazawar zuciya a halin yanzu tana da ma'ana a ci gaba.

- Don dapagliflozin, HFrEF ta rubuta raguwar haɗarin ƙarshen ƙarshen farko tun daga ranar 28 na jiyya, watau ƙasa da wata ɗaya bayan fara magani. Kuma lokacin da aka ƙaddamar da ƙaddamarwar ƙaddamarwa zuwa ziyarar zuwa Sashen Gaggawa na Asibiti (HED), an tabbatar da mahimmancin raguwa a farkon ƙarshen ƙarshen ranar 7! Dole ne a yarda cewa ya zuwa yanzu ba a sami irin waɗannan hanyoyin kwantar da hankali ba, kuma game da haɓakar rayuwa da aka samu godiya ga pharmacotherapy, alal misali a fagen ilimin likitanci (sau da yawa shekaru da watanni), sabbin hanyoyin maganin cututtukan zuciya suna neman zama mai ban sha'awa - in ji Farfesa Małgorzata Lelonek.

Wane magani zan zaɓa?

A cikin sabon tsarin da ke kwatanta mafi kyawun maganin gazawar zuciya, Milton Packer ii John JV McMurray ya ba da shawarar cewa ya kamata a fara jinyar marasa lafiya da ke da raunin zuciya da beta-blocker da phosin.

- Lokacin da muke magana game da manufar jiyya, wanda shine rage yawan mace-mace, a matsayin likita, na zabi wannan haɗin ga marasa lafiya na: beta-blocker da dapagliflozin. Idan ina da majinyata mai haɗari - alal misali, bayan asibiti huɗu a cikin shekarar da ta gabata, burina na farko kuma mafi mahimmanci na jiyya a fili zai kasance don kare rayuwar majiyyaci. Dole ne ku yi aiki da sauri da inganci nan da nan: a cikin gazawar zuciya, lokaci yana da mahimmanci. Ba za mu iya tsara dabarun matakai da yawa tare da gabatar da sannu a hankali na hanyoyin kwantar da hankali ba, saboda… ba za mu iya yin shi akan lokaci ba. A wasu kalmomi, dole ne mu tabbata cewa za mu iya ceton rayuwar majinyacinmu – in ji Farfesa Małgorzata Lelonek.